SPC461
Quizartíníb
Status:
VeittApplication date:
27.3.2024Application published:
15.4.2024Grant published:
15.10.2025
Max expiry date:
13.5.2035Medicine name:
VanflytaMedicine for children:
No
Timeline
Today
27.3.2024Application
15.4.2024Publication
15.10.2025Registration
13.5.2035Expires
Marketing license
IS authorization number:
EU/1/23/1768Date:
28.11.2023
Foreign authorization number:
EU/1/23/1768Date:
6.11.2023
Owner
Name:
Ambit Biosciences CorporationAddress:
211 Mount Airy Road, Basking Ridge, 07920 New Jersey US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2429524
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 08.10.2025